AllergoOncology: Anti-EGFR IgE triggers potent tumor cell killing by mast cells and monocytes (2018)

First Author: Fazekas-Singer J.
Attributed to:  Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 73

Parent Publication: ALLERGY

ISSN: 0105-4538